Literature DB >> 29755162

Bayesian regression model for recurrent event data with event-varying covariate effects and event effect.

Li-An Lin1, Sheng Luo1,1, Barry R Davis1.   

Abstract

In the course of hypertension, cardiovascular disease events (e.g., stroke, heart failure) occur frequently and recurrently. The scientific interest in such study may lie in the estimation of treatment effect while accounting for the correlation among event times. The correlation among recurrent event times come from two sources: subject-specific heterogeneity (e.g., varied lifestyles, genetic variations, and other unmeasurable effects) and event dependence (i.e., event incidences may change the risk of future recurrent events). Moreover, event incidences may change the disease progression so that there may exist event-varying covariate effects (the covariate effects may change after each event) and event effect (the effect of prior events on the future events). In this article, we propose a Bayesian regression model that not only accommodates correlation among recurrent events from both sources, but also explicitly characterizes the event-varying covariate effects and event effect. This model is especially useful in quantifying how the incidences of events change the effects of covariates and risk of future events. We compare the proposed model with several commonly used recurrent event models and apply our model to the motivating lipid-lowering trial (LLT) component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (ALLHAT-LLT).

Entities:  

Keywords:  Event dependence; Frailty model; Heterogeneity; Markov Chain Monte Carlo; Survival model

Year:  2017        PMID: 29755162      PMCID: PMC5945197          DOI: 10.1080/02664763.2017.1367368

Source DB:  PubMed          Journal:  J Appl Stat        ISSN: 0266-4763            Impact factor:   1.404


  15 in total

1.  Survival analysis for recurrent event data: an application to childhood infectious diseases.

Authors:  P J Kelly; L L Lim
Journal:  Stat Med       Date:  2000-01-15       Impact factor: 2.373

2.  Modelling intervention effects after cancer relapses.

Authors:  Juan R González; Edsel A Peña; Elizabeth H Slate
Journal:  Stat Med       Date:  2005-12-30       Impact factor: 2.373

3.  A joint frailty model for survival and gap times between recurrent events.

Authors:  Xuelin Huang; Lei Liu
Journal:  Biometrics       Date:  2007-06       Impact factor: 2.571

Review 4.  Frailty models for survival data.

Authors:  P Hougaard
Journal:  Lifetime Data Anal       Date:  1995       Impact factor: 1.588

5.  Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.

Authors:  B R Davis; J A Cutler; D J Gordon; C D Furberg; J T Wright; W C Cushman; R H Grimm; J LaRosa; P K Whelton; H M Perry; M H Alderman; C E Ford; S Oparil; C Francis; M Proschan; S Pressel; H R Black; C M Hawkins
Journal:  Am J Hypertens       Date:  1996-04       Impact factor: 2.689

6.  Recurrent events and the exploding Cox model.

Authors:  Håkon K Gjessing; Kjetil Røysland; Edsel A Pena; Odd O Aalen
Journal:  Lifetime Data Anal       Date:  2010-07-13       Impact factor: 1.588

7.  Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

Review 8.  Epidemiological studies of CHD and the evolution of preventive cardiology.

Authors:  Nathan D Wong
Journal:  Nat Rev Cardiol       Date:  2014-03-25       Impact factor: 32.419

9.  A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.

Authors:  J E Manson; G A Colditz; M J Stampfer; W C Willett; A S Krolewski; B Rosner; R A Arky; F E Speizer; C H Hennekens
Journal:  Arch Intern Med       Date:  1991-06

10.  Survival and recurrence following stroke. The Framingham study.

Authors:  R L Sacco; P A Wolf; W B Kannel; P M McNamara
Journal:  Stroke       Date:  1982 May-Jun       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.